List of SBIR/STTR awards granted to Enantigen Therapeutics
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Enantigen Therapeutics in September, 2009 for $99,967.0 USD from the U.S. Department of Defense. | STTR | W911NF-09-C-0101 | Phase I | 99,967 | September 1, 2009 | |||||||
A STTR Phase II contract was awarded to Enantigen Therapeutics in December, 2011 for $738,292.0 USD from the U.S. Department of Defense. | STTR | W911NF-12-C-0007 | Phase II | 738,292 | December 16, 2011 | |||||||
A SBIR Phase I contract was awarded to Enantigen Therapeutics for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI104086-01A1 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to Enantigen Therapeutics for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI098200-01A1 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to Enantigen Therapeutics for $282,480.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI084267-01 | Phase I | 282,480 | ||||||||
A SBIR Phase I contract was awarded to Enantigen Therapeutics for $294,674.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI104066-01 | Phase I | 294,674 |
